Most Rosuvastatin side effects are mild, dose-related and settle as treatment continues. The reactions that matter clinically are rare but need to be recognised quickly.
Key takeaways
- Common effects: myalgia, headache, proteinuria at high dose.
- Avoid Rosuvastatin in pregnancy, active liver disease, and caution in Asian patients at 40 mg.
- Dose-related effects often resolve by stepping back one strength.
- Severe or persistent reactions warrant stopping and seeking review.
Frequency bands
| Frequency | Reactions | Action |
|---|---|---|
| Very common (>10%) | myalgia, headache | Usually self-limiting; supportive measures and reassurance. |
| Common (1–10%) | proteinuria at high dose | Review dose and timing; consider dose reduction. |
| Uncommon (<1%) | hypersensitivity, marked laboratory changes | Stop and arrange clinical assessment. |
| Rare | serious organ-specific reactions | Stop immediately; urgent medical attention. |
Reducing the burden
Take Rosuvastatin exactly as directed: 5–10 mg once daily, up to 40 mg in specialist use. Splitting titration into smaller steps, dosing with food where the label allows, and hydrating well cover most tolerability problems seen in practice.
Rosuvastatin at a glance
| Attribute | Detail |
|---|---|
| Drug class | HMG-CoA reductase inhibitor |
| Common brand | Crestor |
| Licensed use | hyperlipidaemia with high-intensity LDL lowering |
| Available strengths | 5, 10, 20, 40 mg |
| Dosage form | film-coated tablet |
| Typical onset | LDL response at 2–4 weeks |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C |